Skip to content
buyWeak

Skycrest Holdings, LLC bought $139k of ZEOX

other at Organicell Regenerative Medicine, Inc.. 46,959 shares at an average of $2.96, traded May 5, 2025, filed May 7, 2025.

Conviction score
31
Value
$139k
46,959 shares
Holdings after
376,607
+14% from before
From 52-week low
+91%
low $1.52, close $2.90
From 52-week high
-28%
high $4.00, as of May 5, 2025

Score components

  • Role
    Other
    +8
  • Trade size
    $139k at market
    +11
  • Relative to holdings
    Holdings up 14%
    +3
  • Price context
    28% below the 52-week high
    +4
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    7 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (1 with prices)
    0

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -32.4%, 3m -50.0%, 6m -38.2%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ZEOXOct 12, 2026 · close 1.16
Since filing May 7, 2025: -60.0%SPY +41.0% · excess -101.0%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001829126-25-003456, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
May 5, 2025POpen-market purchase
Common Stock
+30,500$2.88$88k360,148May 7, 2025
May 6, 2025POpen-market purchase
Common Stock
+500$2.98$1,490360,648May 7, 2025
May 6, 2025POpen-market purchase
Common Stock
+1,000$3.32$3,320361,648May 7, 2025
May 6, 2025POpen-market purchase
Common Stock
+500$3.27$1,635362,148May 7, 2025
May 7, 2025POpen-market purchase
Common Stock
+14,459$3.08$45k376,607May 7, 2025

Related signals

Other insiders at Organicell Regenerative Medicine, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
21Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$12k
6,000 shares
+1%
16Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$8,425
4,002 shares
+1%
16Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$1,048
524 shares
+0%
16Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$275
138 shares
+0%
21Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$22k
11,100 shares
+3%
16Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$7,200
3,500 shares
+1%
22Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$26k
9,500 shares
+2%
17Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$14k
5,000 shares
+1%
21Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$6,793
3,349 shares
+1%
16Weak
ZEOXbuy
Organicell Regenerative Medicine, Inc.
Skycrest Holdings, LLC
other
$2,222
1,001 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Skycrest Holdings, LLC bought $139k of ZEOX | InsiderTell